Abbott Laboratories
ABT · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q3 | October 14, 2026 | — | — | — | — | — |
| 2026 Q2 | July 16, 2026 | 12.59B | 12.52B | 1.31 | 1.28 | +10.71% |
| 2026 Q1 | April 16, 2026 | 11.16B | 11.00B | 1.15 | 1.14 | -6.00% |
| 2025 Q4 | January 22, 2026 | 11.46B | 11.80B | 1.50 | 1.50 | -10.04% |
| 2025 Q3 | October 15, 2025 | 11.37B | 11.39B | 1.30 | 1.30 | -2.87% |
| 2025 Q2 | July 17, 2025 | 11.14B | 11.09B | 1.26 | 1.25 | -8.52% |
| 2025 Q1 | April 16, 2025 | 10.36B | 10.41B | 1.09 | 1.07 | +2.76% |
| 2024 Q4 | January 22, 2025 | 10.97B | 11.03B | 1.34 | 1.34 | +0.85% |
| 2024 Q3 | October 16, 2024 | 10.64B | 10.55B | 1.21 | 1.20 | +1.53% |
| 2024 Q2 | July 18, 2024 | 10.38B | 10.37B | 1.14 | 1.10 | -4.40% |
| 2024 Q1 | April 17, 2024 | 9.96B | 9.88B | 0.98 | 0.96 | -3.03% |
| 2023 Q4 | January 24, 2024 | 10.24B | 10.18B | 1.19 | 1.19 | -2.83% |
| 2023 Q3 | October 18, 2023 | 10.14B | 9.61B | 1.14 | 1.10 | +3.71% |
| 2023 Q2 | July 20, 2023 | 9.98B | 9.70B | 1.08 | 1.04 | +4.24% |
| 2023 Q1 | April 19, 2023 | 9.75B | 9.64B | 1.03 | 0.98 | +7.82% |
| 2022 Q4 | January 25, 2023 | 10.09B | 9.66B | 1.03 | 0.90 | -1.36% |